Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaVoice ↗
How new review policies, the use of AI and other recent FDA changes are being impacted by high turnover at the…
The WeekBioPharma Dive ↗
The ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewh…
The WeekFiercePharma ↗
Bleeding disorder patient groups put Sobi, Roche and Novo Nordisk on the podium in 2025/2026's corporate reput…
The WeekFierceBiotech ↗
The Advanced Research Projects Agency for Health has awarded a new tranche of funds for companies and institut…
The WeekBriefing
The August 5 meeting will explore how to identify and prioritize FDA-approved drugs for new indications and po…
The WeekDrug Channels ↗
Today's guest post comes from Megan Wetzel, Vice President of Product, Access and Affordability at CoverMyMeds…
The WeekPharmaceutical Technology ↗
Apertura has entered a CRADA with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type…
The WeekSTAT News ↗
Jeremy Faust saves lives in the ER and breaks stories with his Inside Medicine newsletter. He's also testing t…
The WeekBioPharma Dive ↗
The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, w…
The WeekPharmaVoice ↗
PharmaVoice checked in with four life sciences executives after they landed a new role. Now they're looking ba…
The WeekFiercePharma ↗
Allergan Aesthetics on Tuesday welcomed Girls Inc. participants to a panel and tour at its Allergan Medical In…
The WeekFierceBiotech ↗
The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, F…
The WeekBriefing
The newly approved Dexcom Stelo continuous glucose monitor opens access beyond diabetes management, prompting …
The WeekSTAT News ↗
Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer tre…
The WeekBioPharma Dive ↗
The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of suc…
The WeekPharmaVoice ↗
U.S. clinical trials continue to lose ground to China, but is Operation Trialblazer enough to help America cat…
The WeekFiercePharma ↗
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees…
The WeekFierceBiotech ↗
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challeng…
The WeekBriefing
Vertex’s Casgevy can now treat sickle cell disease and transfusion-dependent beta thalassemia in patients aged…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.For years, the controversy surrounding the 340B Drug Pricing Program has centered on hos…
The WeekSTAT News ↗
The White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, em…
The WeekBioPharma Dive ↗
The funding deal is a vote of confidence in the sales potential of multiple prospects in late-stage developmen…
The WeekPharmaVoice ↗
While rivals scramble to replace lost revenue, Lilly is opening an unprecedented gap by being a "contrarian," …
The WeekFiercePharma ↗
Skin quality affects quality of life for 85% of people, leaving more than one-third of individuals feeling sel…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.